News | March 13, 2025
Alkem launches generic empagliflozin and its combinations in India under ‘Empanorm’
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
The workshop aimed to equip medicos with the necessary skills & knowledge to leverage AI's transformative power
India has taken the lead in recognising NAFLD as a major non-communicable disease
‘Unmask Anemia’ aims to simplify assessment of iron deficiency anemia risk with an easy online self-test based on common signs and symptoms
CiplaMed 2.0 leverages advanced analytics and automation
Introduces a line-up of brands targeting key therapeutic categories for its ophthalmology segment launc
'Hello Skin' has been developed in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists and Leprologists)
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
Subscribe To Our Newsletter & Stay Updated
